Verrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA Approval
By Denny Jacob
Verrica Pharmaceuticals on Friday said the Food and Drug Administration approved Ycanth topical solution to treat molluscum contagiosum in adults and patients ages two and up.
The dermatology therapeutics company said it plans to make Ycanth available by September.
Molluscum contagiosum is an infection caused by a poxvirus, which can result in a benign, mild skin disease characterized by growths on the body.
Chief Executive Ted White said molluscum contagiosum primarily affects children and is commonly transmitted in households, schools and swimming pools through skin-to-skin contact given its highly contagious nature.
Trading of the company's stock was halted at 3:58 p.m. ET ahead of the news.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
July 21, 2023 16:50 ET (20:50 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth